Madabushi R - Search Results

1

Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.

Blaus A, Madabushi R, Pacanowski M, Rose M, Schuck RN, Stockbridge N, Temple R, Unger EF. Blaus A, et al. Among authors: madabushi r. Circulation. 2015 Oct 13;132(15):1425-32. doi: 10.1161/CIRCULATIONAHA.114.009761. Circulation. 2015. PMID: 26459078

2

Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review.

Garnett CE, Beasley N, Bhattaram VA, Jadhav PR, Madabushi R, Stockbridge N, Tornøe CW, Wang Y, Zhu H, Gobburu JV. Garnett CE, et al. Among authors: madabushi r. J Clin Pharmacol. 2008 Jan;48(1):13-8. doi: 10.1177/0091270007307881. J Clin Pharmacol. 2008. PMID: 18094216 Review.

3

Misclassification and discordance of measured blood pressure from patient's true blood pressure in current clinical practice: a clinical trial simulation case study.

Jin Y, Bies R, Gastonguay MR, Stockbridge N, Gobburu J, Madabushi R. Jin Y, et al. Among authors: madabushi r. J Pharmacokinet Pharmacodyn. 2012 Jun;39(3):283-94. doi: 10.1007/s10928-012-9250-8. Epub 2012 May 9. J Pharmacokinet Pharmacodyn. 2012. PMID: 22569889 Clinical Trial.

4

Predicted impact of various clinical practice strategies on cardiovascular risk for the treatment of hypertension: a clinical trial simulation study.

Jin Y, Bies R, Gastonguay MR, Wang Y, Stockbridge N, Gobburu J, Madabushi R. Jin Y, et al. Among authors: madabushi r. J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):693-704. doi: 10.1007/s10928-014-9394-9. Epub 2014 Oct 18. J Pharmacokinet Pharmacodyn. 2014. PMID: 25326066 Clinical Trial.

5

Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved Drugs.

Schuck RN, Pacanowski M, Kim S, Madabushi R, Zineh I. Schuck RN, et al. Among authors: madabushi r. Clin Transl Sci. 2019 May;12(3):236-239. doi: 10.1111/cts.12626. Epub 2019 Mar 12. Clin Transl Sci. 2019. PMID: 30791226 Free PMC article.

6

The US Food and Drug Administration's Model-Informed Drug Development Paired Meeting Pilot Program: Early Experience and Impact.

Madabushi R, Benjamin JM, Grewal R, Pacanowski MA, Strauss DG, Wang Y, Zhu H, Zineh I. Madabushi R, et al. Clin Pharmacol Ther. 2019 Jul;106(1):74-78. doi: 10.1002/cpt.1457. Epub 2019 May 13. Clin Pharmacol Ther. 2019. PMID: 31081932 No abstract available.

7

Regulatory Efforts to Facilitate Evaluation and Clinical Management of Drug-Drug Interaction Risks.

Yang X, Pfuma Fletcher E, Huang SM, Zineh I, Madabushi R. Yang X, et al. Among authors: madabushi r. Clin Pharmacol Ther. 2021 Jan;109(1):42-46. doi: 10.1002/cpt.1984. Epub 2020 Jul 28. Clin Pharmacol Ther. 2021. PMID: 32721040 Review. No abstract available.

8

A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response-Guided Titration.

Wang L, Maxfield K, Guinn D, Madabushi R, Zineh I, Schuck RN. Wang L, et al. Among authors: madabushi r. Clin Pharmacol Ther. 2021 Jan;109(1):123-130. doi: 10.1002/cpt.2068. Epub 2020 Nov 15. Clin Pharmacol Ther. 2021. PMID: 33022770 Free PMC article.

9

Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting.

Sahre MD, Milligan L, Madabushi R, Graham RA, Reynolds KS, Terzic A, Benjamin J, Burckart GJ, Huang SM, Schuck R, Thompson AM, Zineh I. Sahre MD, et al. Among authors: madabushi r. Clin Pharmacol Ther. 2021 Aug;110(2):285-288. doi: 10.1002/cpt.2151. Epub 2021 Feb 16. Clin Pharmacol Ther. 2021. PMID: 33411946

10

Roadmap to 2030 for Drug Evaluation in Older Adults.

Liu Q, Schwartz JB, Slattum PW, Lau SWJ, Guinn D, Madabushi R, Burckart G, Califf R, Cerreta F, Cho C, Cook J, Gamerman J, Goldsmith P, van der Graaf PH, Gurwitz JH, Haertter S, Hilmer S, Huang SM, Inouye SK, Kanapuru B, Pirmohamed M, Posner P, Radziszewska B, Keipp Talbot H, Temple R. Liu Q, et al. Among authors: madabushi r. Clin Pharmacol Ther. 2022 Aug;112(2):210-223. doi: 10.1002/cpt.2452. Epub 2021 Nov 8. Clin Pharmacol Ther. 2022. PMID: 34656074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters